SureTrader Advertisement
Home > Boards > US Listed > Medical - Drugs > Galena Biopharma (GALE)

I sold my last shares of Gale this

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
noretreat Member Profile
 
Followed By 119
Posts 9,133
Boards Moderated 3
Alias Born 01/06/10
160x600 placeholder
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/29/2016 7:07:50 AM
Galena Biopharma Discontinues NeuVax™ (nelipepimut-S) Phase 3, PRESENT Interim Analysis based on Independent Data Monitorin... "GlobeNewswire Inc." - 6/29/2016 7:05:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/28/2016 8:24:48 AM
Biotechnology Stocks Under Review - Eleven Biotherapeutics, Relypsa, Galena Biopharma, and Amgen "PR Newswire (US)" - 6/20/2016 8:25:00 AM
Galena Biopharma Presents GALE-401 Combined Safety Data at the European Hematology Association 21st Congress "GlobeNewswire Inc." - 6/13/2016 7:05:00 AM
Galena Biopharma Receives Two Orphan Drug Designations for GALE-301 and GALE-301/GALE-302 "GlobeNewswire Inc." - 6/10/2016 2:47:11 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) "Edgar (US Regulatory)" - 6/9/2016 5:11:12 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/7/2016 6:37:50 PM
Purcell Julie & Lefkowitz LLP Is Investigating Galena Biopharma, Inc. for Potential Breaches Of Fiduciary ... "PR Newswire (US)" - 6/7/2016 7:12:00 AM
Galena Biopharma Presents GALE-301 Phase 1/2a Primary Analysis at the American Society of Clinical Oncology Annual Meeting 20... "GlobeNewswire Inc." - 6/6/2016 2:00:00 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) "Edgar (US Regulatory)" - 6/3/2016 4:46:08 PM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 6/3/2016 4:29:14 PM
Galena Biopharma Receives Fast Track Designation for NeuVax™ (nelipepimut-S) PRESENT Clinical Trial "GlobeNewswire Inc." - 6/1/2016 7:05:00 AM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) "Edgar (US Regulatory)" - 5/24/2016 5:25:48 PM
Small Company Offering and Sale of Securities Without Registration (d) "Edgar (US Regulatory)" - 5/24/2016 12:02:01 PM
Galena Biopharma to Present at the Sachs Associates 2nd Annual Immuno-Oncology BD&L and Investment Forum "GlobeNewswire Inc." - 5/24/2016 7:05:00 AM
Galena Biopharma to Present GALE-401 Combined Safety Data at the European Hematology Association 21st Congress "GlobeNewswire Inc." - 5/19/2016 12:15:00 PM
Galena Biopharma to Present the GALE-301 Phase 1/2a Primary Analysis at the American Society of Clinical Oncology Annual Meet... "GlobeNewswire Inc." - 5/18/2016 5:45:48 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/10/2016 5:40:39 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/10/2016 5:30:39 PM
Galena Biopharma Reports First Quarter 2016 Financial Results and Provides a Corporate Update "GlobeNewswire Inc." - 5/10/2016 4:10:00 PM
Amended Annual Report (10-k/a) "Edgar (US Regulatory)" - 4/29/2016 6:20:17 PM
Confidential Treatment Order (ct Order) "Edgar (US Regulatory)" - 4/29/2016 11:27:51 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/28/2016 6:18:15 PM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 4/28/2016 6:08:44 PM
noretreat   Friday, 02/14/14 10:25:43 AM
Re: None
Post # of 8727 
I sold my last shares of Gale this morning, after lightening up by 90% over the previous month. It looks like these issues aren't going to go away quickly, and management does not seem to want to address them. Riding the run-up was nice.

Does not look like the CLDX of 2014 anymore, but who knows? There should be a bounce here a some point.

Men fear thought as they fear nothing else on earth -- more than ruin, more even than death. Thought is subversive and revolutionary, destructive and terrible, thought is merciless to privilege, established institutions, and comfortable habits.(Russell)
SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist